"Anywhere from 300 to 3,000 participants are required to conduct Phase III clinical trials. Phase III trials have the largest base of patients, all living with the targeted condition that the drug id intended to treat.
As the most time-consuming and demanding trial in which to be involved, Phase III research uses patients with similar demographic traits and tests them for a duration of two to five years."
News 
Market Data 
Discover 
